Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1302 -0.0098 (-7.00%)
Streaming Delayed Price Updated: 9:43 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 Next >
Despite Recent Progress, Zomedica Has to Prove Its Value
Despite releasing Truforma ahead of schedule, Zomedica still has to overcome tough challenges facing the product. ZOM stock isn't a buy yet. 
Via InvestorPlace
42 Biggest Movers From Yesterday
Gainers Esports Technologies, Inc. (NASDAQ: EBET) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: AGL) gained 34.8% to close at $31.00 after the... 
Via Benzinga
Why Zomedica Stock Plunged Today
Initial sales of a key product may be lower than investors were hoping for. 
Via The Motley Fool
30 Stocks Moving In Thursday's Mid-Day Session
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 58.2% to $13.16 after gaining 14% on Wednesday. The company's 13D filing recently showed that Modell'... 
Via Benzinga
The Party’s Over for Zomedica Stock, So Stay Away
After falling back to $1 per share, expect headline-making "meme stock" ZOM stock to give up even more of its recent gains. 
Via InvestorPlace
Zomedica’s Price Has Changed but So Has the Narrative
With the market speaking loud and clear on ZOM stock, you don’t want to rush into this cheapened investment. 
Via InvestorPlace
22 Stocks Moving in Thursday's Pre-Market Session
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) rose 25.1% to $0.6485 in pre-market trading. Bit Digital, Inc. (NASDAQ: BTBT) rose 15.1% to $16.40 in pre-market trading after... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Galectin Therapeutics Inc. (NASDAQ: GALT) rose 37.6% to $2.98 in pre-market trading after the company said a paper published in the peer-reviewed Journal for... 
Via Benzinga
Should You Buy Zomedica in April?
The stock has been falling sharply in the past month. 
Via The Motley Fool
Zomedica Really Only Has Its Penny Status Keeping It Interesting
The past year has been great for pet-related stocks, and ZOM stock is as much a perfect example as it is a cautionary tale. 
Via InvestorPlace
Zomedica Stock Pullback Opens Door for Investors To Take a Small Position
Has ZOM stock bottomed or does it have further to fall? Investors who are interested in buying stock of animal health company Zomedica may want to pull the trigger with the share price down 47% since... 
Via InvestorPlace
You Don’t Want to Be the Last to Know What Zomedica Stock Is Realy Worth
The retirement of preferred stock seems like a clear win for Zomedica and ZOM stock. But the deal raises a key question as well. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Do Not Bet on Zomedica… At Least Not Yet
The early launch of Zomedica's Truforma does not guarantee commercial success. Before you bet on ZOM stock, the company needs to prove itself. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.